In a post-hoc exploratory analysis of the KING trial to seek molecular markers of outcome, RNAseq was performed on resected tumor specimens at the time of diagnostic surgery before the recurrence from

NIAID Data Ecosystem30

Supplementary Table 3 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

癌症基因组数据

肿瘤分子标志物

Genes differentially expressed in RB1 loss tumors with two or more RB1 mutations

NIAID Data Ecosystem20

PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients

胶质母细胞瘤预后

肿瘤分子标志物

PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients

ChEBI2025-12-04 更新30

Association between ecDNA and outcome of patients.

肿瘤分子标志物

临床预后分析

Association between ecDNA and outcome of patients.

Figshare2025-12-04 更新30

Expression data from meningiomas and normal meninges

资源简介：

相关数据集